Newsbenzinga
Sino Biopharma Accelerates Global Growth With GSK, AstraZeneca Partnerships
· Published
Article summary
Sino Biopharma expanded its GSK partnership in China and signed an AstraZeneca licensing deal worth up to $2.1 billion.
An excerpt from the original article.
Comments —
Loading comments…